Saturday, 15 June 2019

Week 201 Review - Another slide downwards

The drip drip slide of the last few weeks has continued, with a drop in value of £1,408 all caused by a 2p slip in OPTI:Optibiotix. Fortunately some other shares did OK so the losses were less than the £1,640 OPTI dropped. The deficit betwen cost and value is now £5,714 and total portfolio value is £95,825.

JLP:Jubilee Metals has been on a good run lately but dropped 5% this week as people took profits. They are 33% down and losing £1,514 but for the first time in a while my confidence is growing that they could come good. They just need to focus on getting profitable before they spend yet more cash.

TAP:Taptica had another desperate week and fell 5% but it could have been worse after an announcement they are being sued by Uber. It sounds like a dodgy case so hopefully it will go away, but these are down 64% now so it's a long haul back to profit.

Apart from the small drop in OPTI:Optibiotix, it wasn't a bad week for risers. CEY:Centamin climbed 8% for the second week in a row. My ISA holding is still down 15% and losing £236, but very happy to say my SIPP holding is up 6% and making £165 potential profit. This is a long term holding though.

VRS:Versarien climbed an impressive 11% and has gone back into profit. My holding is now 9% up and making £128 potential profit. Slightly worried that there are stories about our man in America being prosecuted, but they are from sources that have always been negative about VRS and may have short interests. If the price does drop on Monday it's just another buying opportunity.

Share of the Week is TEK:Tekcapital which climbed 15% and is now only 15% down. I only have a small holding in my trading account, but with the huge spread the offer price is almost what I paid for them, and it moves really fast when it does go up. Fingers crossed!



I keep saying not good - because it isn't.




Below the trend line is deeply upsetting

Here's the performance of the ISA and share accounts



Weekly Change
Cash £23.23
+£0
Portfolio cost £57,827.12
+£0
Portfolio sell value (bid price-commission) £52,879.83 (-8.6%) -£1,162.55
Potential profits £5,806.35
-£1,011.92
Yr 4 Dividends £88.07
+£0
Yr 4 Profit from sales £1,606.13
+£0
Yr 4 Average monthly cash profit £159.53 (3.3%) -£3.63
Total Dividends £1,326.40
+£0
Total Profit from sales £20,303.25
+£0
Average monthly cash profit £462.34 (9.6%) -£2.31
(Sold stocks profit + Dividends - Fees
 / Months)

Not much to say. Losses deepened slightly more than the lost OPTI:Optibiotix profits, and IQE:IQE went back into the red so removed that small profit too. TND:Tandem is my other profitable share but that's dropped to £4 so isn't going to set my performance on fire if I sell now. I have a limit sell order in but it's 30% higher than the current price. This share is so illiquid it could potentially move that far in a few days.




Just like the overall chart




Not quite below the trend line which is a crumb of comfort.

The SIPP looks like this after week 185



Weekly Change
Cash £84.80
+£0
Portfolio cost £41,248.68
+£0
Portfolio sell value (bid price - commission) £41,260.61 (0%) -£281.09
Potential profits £4,154.18
-£368.11
Yr 4 Dividends £361.99
+£0
Yr 4 Interest £0.07
+£0
Yr 4 Profit from sales £732.65
+£0
Yr 4 Average monthly cash profit £149.89 (4.4%) -£5.35
Total Dividends £1,704.24
+£0
Total Interest £0.10
+£0
Total Profit from sales £11,277.57
+£0
Average monthly cash profit £295.33 (8.6%) -£1.60
(Sold stocks profit + Dividends - Fees
/ Months)

Very little change, with the loss in OPTI:Optibiotix profits mitigated by the rises in CEY:Centamin and VRS:Versarien. My average performance has slipped to 8.6%. I need to get the average monthly profit up to £343 a month to hit 10% which is £48 a month more than I am on now, and I've been going for about 45 months. That makes £2,160 profit from one sale to get back on track. Quite a tall ask!




Still just the right side of the red line.




No doubt that performance is getting worse every week.

The trading account looks like this after week 151



Weekly Change
Cash £35.04
+£0
Portfolio cost £2,321.29
+£0
Portfolio sell value (bid price - commission) £1,542.22 (-33.6%) +£46.68
Potential profits £0
+£0
Year 3 Dividends £33.57
+£0
Year 3 Profit £177.06
+£0
Yr 3 Average monthly cash profit £19.42 (10%) -£0.42
Dividends £34.72
+£0
Profit from sales -£64.29
+£0
Average monthly cash profit -£0.85 (-0.4%) +£0
(Sold stocks profit + Dividends - Fees
 / Months)

A great week thanks to TEK:Tekcapital and despite losses elsewhere. I think there's a glimmer of hope here.




It's been sneaking upwards for about 6 months now but will take about 5 years to break even at this rate.




The trend line will get a lot steeper before it starts to flatten, but we're on the right side of it.

I have a feeling I may get to sell something next week. There are a few shares simmering and hopefully contemplating a spike upwards.

How are my 2 attempted trades in the ISA going?

I sold SBTX:SkinBioTherapeutics for 23.2p a few weeks ago and they are now 23p to buy. Ideally I want them to drop to below 20p before I get back in. I invested the proceeds in IQE:IQE which I bought at 75.0795p and they are now 75.2p to sell, so I'd lose £20 commission. I really need these to get to about 84p before selling and buying back SBTX.

I sold CWR:Ceres Power for 184.1p and they are now 176p to buy, so that's gone in the right direction. Unfortunately my investment in C4XD:C4X Discovery Holdings bought at 48p is still 47p to sell and hasn't really moved, although it is 50p to buy now. I need that to get to 54p bid price, and for CWR to drop to arond 160p.

It's probably a stupid thing to try and pull off - I should have just kept the cash rather than re-investing. It's worth a try though...

No comments:

Post a Comment